PETER RUVOLO

TitleAssistant Professor
InstitutionMD Anderson
DepartmentLeukemia
Address1400 Holcombe Blvd
Houston TX 77030-4008
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Post SM, Andreeff M, DiNardo C, Khoury JD, Ruvolo PP. TAM kinases as regulators of cell death. Biochim Biophys Acta Mol Cell Res. 2021 May; 1868(6):118992. PMID: 33647320.
      Citations:    Fields:    
    2. Hoff FW, van Dijk AD, Qiu Y, Ruvolo PP, Gerbing RB, Leonti AR, Jenkins GN, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, de Bont ESJM, Bruggeman SWM, Kornblau SM, Horton TM. Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report. Blood. 2021 Feb 25; 137(8):1050-1060. PMID: 32959058.
      Citations:    Fields:    
    3. Ruvolo PP, Ma H, Ruvolo VR, Zhang X, Post SM, Andreeff M. LGALS1 acts as a pro-survival molecule in AML. Biochim Biophys Acta Mol Cell Res. 2020 10; 1867(10):118785. PMID: 32590026.
      Citations:    Fields:    Translation:HumansAnimalsCells
    4. Liu Z, Yoshimi A, Wang J, Cho H, Chun-Wei Lee S, Ki M, Bitner L, Chu T, Shah H, Liu B, Mato AR, Ruvolo P, Fabbri G, Pasqualucci L, Abdel-Wahab O, Rabadan R. Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization. Cancer Discov. 2020 Jun; 10(6):806-821. PMID: 32188705.
      Citations: 6     Fields:    
    5. Ohanian M, Telouk P, Kornblau S, Albarede F, Ruvolo P, Tidwell RSS, Plesa A, Kanagal-Shamanna R, Matera EL, Cortes J, Carson A, Dumontet C. A heavy metal baseline score predicts outcome in acute myeloid leukemia. Am J Hematol. 2020 Apr; 95(4):422-434. PMID: 31944361.
      Citations:    Fields:    
    6. Akula SM, Ruvolo PP, McCubrey JA. TP53/miR-34a-associated signaling targets SERPINE1 expression in human pancreatic cancer. Aging (Albany NY). 2020 01 27; 12(3):2777-2797. PMID: 31986125.
      Citations: 1     Fields:    Translation:HumansCells
    7. Perrotti D, Agarwal A, Lucas CM, Narla G, Neviani P, Odero MD, Ruvolo PP, Verrills NM. Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia". Sci Transl Med. 2019 07 17; 11(501). PMID: 31316003.
      Citations: 1     Fields:    Translation:HumansCells
    8. Ruvolo PP, Hu CW, Qiu Y, Ruvolo VR, Go RL, Hubner SE, Coombes KR, Andreeff M, Qutub AA, Kornblau SM. LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML. EBioMedicine. 2019 Jun; 44:126-137. PMID: 31105032.
      Citations: 3     Fields:    Translation:HumansCells
    9. Ruvolo PP. Galectins as regulators of cell survival in the leukemia niche. Adv Biol Regul. 2019 01; 71:41-54. PMID: 30245264.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    10. Ruvolo PP. Role of protein phosphatases in the cancer microenvironment. Biochim Biophys Acta Mol Cell Res. 2019 01; 1866(1):144-152. PMID: 30026077.
      Citations: 7     Fields:    Translation:HumansCells
    11. Ohanian M, Rozovski U, Kanagal-Shamanna R, Abruzzo LV, Loghavi S, Kadia T, Futreal A, Bhalla K, Zuo Z, Huh YO, Post SM, Ruvolo P, Garcia-Manero G, Andreeff M, Kornblau S, Borthakur G, Hu P, Medeiros LJ, Takahashi K, Hornbaker MJ, Zhang J, Nogueras-González GM, Huang X, Verstovsek S, Estrov Z, Pierce S, Ravandi F, Kantarjian HM, Bueso-Ramos CE, Cortes JE. MYC protein expression is an important prognostic factor in acute myeloid leukemia. Leuk Lymphoma. 2019 01; 60(1):37-48. PMID: 29741984.
      Citations: 12     Fields:    Translation:Humans
    12. Ruvolo PP, Ruvolo VR, Burks JK, Qiu Y, Wang RY, Shpall EJ, Mirandola L, Hail N, Zeng Z, McQueen T, Daver N, Post SM, Chiriva-Internati M, Kornblau SM, Andreeff M. Role of MSC-derived galectin 3 in the AML microenvironment. Biochim Biophys Acta Mol Cell Res. 2018 07; 1865(7):959-969. PMID: 29655803.
      Citations: 2     Fields:    Translation:HumansCells
    13. Kornblau SM, Ruvolo PP, Wang RY, Battula VL, Shpall EJ, Ruvolo VR, McQueen T, Qui Y, Zeng Z, Pierce S, Jacamo R, Yoo SY, Le PM, Sun J, Hail N, Konopleva M, Andreeff M. Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival. Haematologica. 2018 05; 103(5):810-821. PMID: 29545342.
      Citations: 10     Fields:    Translation:HumansCells
    14. Jiang X, Mak PY, Mu H, Tao W, Mak DH, Kornblau S, Zhang Q, Ruvolo P, Burks JK, Zhang W, McQueen T, Pan R, Zhou H, Konopleva M, Cortes J, Liu Q, Andreeff M, Carter BZ. Disruption of Wnt/ß-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in FLT3-Mutant Acute Myeloid Leukemia. Clin Cancer Res. 2018 05 15; 24(10):2417-2429. PMID: 29463558.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    15. Shaim H, Estrov Z, Harris D, Hernandez Sanabria M, Liu Z, Ruvolo P, Thompson PA, Ferrajoli A, Daher M, Burger J, Muftuoglu M, Imahashi N, Li L, Liu E, Alsuliman AS, Basar R, Nassif Kerbauy L, Sobieski C, Gokdemir E, Kondo K, Wierda W, Keating M, Shpall EJ, Rezvani K. The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide. Front Immunol. 2017; 8:1773. PMID: 29379494.
      Citations: 7     Fields:    
    16. Steelman LS, Abrams SL, Ruvolo P, Ruvolo V, Cocco L, Ratti S, Martelli AM, Neri LM, Candido S, Libra M, McCubrey JA. Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression. Oncotarget. 2017 Dec 22; 8(68):113013-113033. PMID: 29348885.
      Citations: 1     Fields:    
    17. Ruvolo PP, Ma H, Ruvolo VR, Zhang X, Mu H, Schober W, Hernandez I, Gallardo M, Khoury JD, Cortes J, Andreeff M, Post SM. Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms. Haematologica. 2017 12; 102(12):2048-2057. PMID: 28912176.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    18. Abrams SL, Ruvolo PP, Ruvolo VR, Ligresti G, Martelli AM, Cocco L, Ratti S, Tafuri A, Steelman LS, Candido S, Libra M, McCubrey JA. Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells. Oncotarget. 2017 Sep 29; 8(44):76525-76557. PMID: 29100331.
      Citations: 1     Fields:    
    19. Mirandola L, Pedretti E, Figueroa JA, Chiaramonte R, Colombo M, Chapman C, Grizzi F, Patrinicola F, Kast WM, Nguyen DD, Rahman RL, Daver N, Ruvolo P, Post SM, Bresalier RS, Chiriva-Internati M. Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy. Oncotarget. 2017 Sep 26; 8(43):74378-74390. PMID: 29088794.
      Citations: 6     Fields:    
    20. Jacamo R, Davis RE, Ling X, Sonnylal S, Wang Z, Ma W, Zhang M, Ruvolo P, Ruvolo V, Wang RY, McQueen T, Lowe S, Zuber J, Kornblau SM, Konopleva M, Andreeff M. Tumor Trp53 status and genotype affect the bone marrow microenvironment in acute myeloid leukemia. Oncotarget. 2017 Oct 13; 8(48):83354-83369. PMID: 29137349.
      Citations: 4     Fields:    
    21. Ruvolo PP. GSK-3 as a novel prognostic indicator in leukemia. Adv Biol Regul. 2017 08; 65:26-35. PMID: 28499784.
      Citations: 6     Fields:    Translation:HumansCells
    22. Van Roosbroeck K, Fanini F, Setoyama T, Ivan C, Rodriguez-Aguayo C, Fuentes-Mattei E, Xiao L, Vannini I, Redis RS, D'Abundo L, Zhang X, Nicoloso MS, Rossi S, Gonzalez-Villasana V, Rupaimoole R, Ferracin M, Morabito F, Neri A, Ruvolo PP, Ruvolo VR, Pecot CV, Amadori D, Abruzzo L, Calin S, Wang X, You MJ, Ferrajoli A, Orlowski R, Plunkett W, Lichtenberg TM, Davuluri RV, Berindan-Neagoe I, Negrini M, Wistuba II, Kantarjian HM, Sood AK, Lopez-Berestein G, Keating MJ, Fabbri M, Calin GA. Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers. Clin Cancer Res. 2017 06 01; 23(11):2891-2904. PMID: 27903673.
      Citations: 40     Fields:    Translation:HumansAnimalsCells
    23. Ruvolo PP. Editorial: The Emerging Role for PP2A in Hematologic Malignancies. Front Oncol. 2016; 6:195. PMID: 27630825.
      Citations:    
    24. Dany M, Gencer S, Nganga R, Thomas RJ, Oleinik N, Baron KD, Szulc ZM, Ruvolo P, Kornblau S, Andreeff M, Ogretmen B. Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML. Blood. 2016 10 13; 128(15):1944-1958. PMID: 27540013.
      Citations: 37     Fields:    Translation:HumansAnimalsCells
    25. Ruvolo PP. The broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance. BBA Clin. 2016 Dec; 6:87-99. PMID: 27556014.
      Citations: 47     
    26. Piya S, Kornblau SM, Ruvolo VR, Mu H, Ruvolo PP, McQueen T, Davis RE, Hail N, Kantarjian H, Andreeff M, Borthakur G. Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia. Blood. 2016 09 01; 128(9):1260-9. PMID: 27268264.
      Citations: 22     Fields:    Translation:HumansAnimalsCells
    27. Ishizawa J, Kojima K, Chachad D, Ruvolo P, Ruvolo V, Jacamo RO, Borthakur G, Mu H, Zeng Z, Tabe Y, Allen JE, Wang Z, Ma W, Lee HC, Orlowski R, Sarbassov dos D, Lorenzi PL, Huang X, Neelapu SS, McDonnell T, Miranda RN, Wang M, Kantarjian H, Konopleva M, Davis RE, Andreeff M. ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies. Sci Signal. 2016 Feb 16; 9(415):ra17. PMID: 26884599.
      Citations: 64     Fields:    Translation:AnimalsCells
    28. Semenza GL, Ruvolo PP. Introduction to tumor microenvironment regulation of cancer cell survival, metastasis, inflammation, and immune surveillance. Biochim Biophys Acta. 2016 Mar; 1863(3):379-381. PMID: 26721622.
      Citations: 9     Fields:    Translation:Humans
    29. Ruvolo PP, Ruvolo VR, Benton CB, AlRawi A, Burks JK, Schober W, Rolke J, Tidmarsh G, Hail N, Davis RE, Andreeff M. Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells. Biochim Biophys Acta. 2016 Apr; 1863(4):562-71. PMID: 26704388.
      Citations: 9     Fields:    Translation:HumansCells
    30. Borthakur G, Duvvuri S, Ruvolo V, Tripathi DN, Piya S, Burks J, Jacamo R, Kojima K, Ruvolo P, Fueyo-Margareto J, Konopleva M, Andreeff M. MDM2 Inhibitor, Nutlin 3a, Induces p53 Dependent Autophagy in Acute Leukemia by AMP Kinase Activation. PLoS One. 2015; 10(10):e0139254. PMID: 26440941.
      Citations: 7     Fields:    Translation:HumansCells
    31. Ruvolo PP. Galectin 3 as a guardian of the tumor microenvironment. Biochim Biophys Acta. 2016 Mar; 1863(3):427-437. PMID: 26264495.
      Citations: 52     Fields:    Translation:Humans
    32. Ruvolo PP, Qiu Y, Coombes KR, Zhang N, Neeley ES, Ruvolo VR, Hail N, Borthakur G, Konopleva M, Andreeff M, Kornblau SM. Phosphorylation of GSK3a/ß correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients. BBA Clin. 2015 Dec; 4:59-68. PMID: 26674329.
      Citations: 14     
    33. Lesyk G, Fong T, Ruvolo PP, Jurasz P. The potential of enzastaurin to enhance platelet aggregation and growth factor secretion: implications for cancer cell survival. J Thromb Haemost. 2015 Aug; 13(8):1514-20. PMID: 25990653.
      Citations: 3     Fields:    Translation:HumansCells
    34. Pan R, Ruvolo VR, Wei J, Konopleva M, Reed JC, Pellecchia M, Andreeff M, Ruvolo PP. Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia. Blood. 2015 Jul 16; 126(3):363-72. PMID: 26045609.
      Citations: 44     Fields:    Translation:HumansAnimalsCells
    35. Ruvolo PP. The Interplay between PP2A and microRNAs in Leukemia. Front Oncol. 2015; 5:43. PMID: 25750899.
      Citations: 7     
    36. Ruvolo PP, Ruvolo VR, Jacamo R, Burks JK, Zeng Z, Duvvuri SR, Zhou L, Qiu Y, Coombes KR, Zhang N, Yoo SY, Pan R, Hail N, Konopleva M, Calin G, Kornblau SM, Andreeff M. The protein phosphatase 2A regulatory subunit B55a is a modulator of signaling and microRNA expression in acute myeloid leukemia cells. Biochim Biophys Acta. 2014 Sep; 1843(9):1969-77. PMID: 24858343.
      Citations: 19     Fields:    Translation:HumansCells
    37. Mak PY, Mak DH, Mu H, Shi Y, Ruvolo P, Ruvolo V, Jacamo R, Burks JK, Wei W, Huang X, Kornblau SM, Andreeff M, Carter BZ. Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AML. Apoptosis. 2014 Apr; 19(4):698-707. PMID: 24337870.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    38. Jacamo R, Chen Y, Wang Z, Ma W, Zhang M, Spaeth EL, Wang Y, Battula VL, Mak PY, Schallmoser K, Ruvolo P, Schober WD, Shpall EJ, Nguyen MH, Strunk D, Bueso-Ramos CE, Konoplev S, Davis RE, Konopleva M, Andreeff M. Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-?B mediates chemoresistance. Blood. 2014 Apr 24; 123(17):2691-702. PMID: 24599548.
      Citations: 89     Fields:    Translation:HumansAnimalsCells
    39. Konopleva MY, Walter RB, Faderl SH, Jabbour EJ, Zeng Z, Borthakur G, Huang X, Kadia TM, Ruvolo PP, Feliu JB, Lu H, Debose L, Burger JA, Andreeff M, Liu W, Baggerly KA, Kornblau SM, Doyle LA, Estey EH, Kantarjian HM. Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemia. Clin Cancer Res. 2014 Apr 15; 20(8):2226-35. PMID: 24583795.
      Citations: 30     Fields:    Translation:HumansCellsCTClinical Trials
    40. Pan R, Hogdal LJ, Benito JM, Bucci D, Han L, Borthakur G, Cortes J, DeAngelo DJ, Debose L, Mu H, Döhner H, Gaidzik VI, Galinsky I, Golfman LS, Haferlach T, Harutyunyan KG, Hu J, Leverson JD, Marcucci G, Müschen M, Newman R, Park E, Ruvolo PP, Ruvolo V, Ryan J, Schindela S, Zweidler-McKay P, Stone RM, Kantarjian H, Andreeff M, Konopleva M, Letai AG. Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia. Cancer Discov. 2014 Mar; 4(3):362-75. PMID: 24346116.
      Citations: 190     Fields:    Translation:HumansAnimalsCells
    41. Moncada de la Rosa C, Radziwon-Balicka A, El-Sikhry H, Seubert J, Ruvolo PP, Radomski MW, Jurasz P. Pharmacologic protein kinase Ca inhibition uncouples human platelet-stimulated angiogenesis from collagen-induced aggregation. J Pharmacol Exp Ther. 2013 Apr; 345(1):15-24. PMID: 23386249.
      Citations: 5     Fields:    Translation:HumansCells
    42. Ruvolo PP. The Herculean task of killing cancer cells: suppression of FOXO3A in acute leukemia involves a hydra of multiple survival kinases. Cell Cycle. 2012 Jul 15; 11(14):2589. PMID: 22751430.
      Citations: 3     Translation:Humans
    43. Butko NJ, Ruvolo P, Whitehill J, Bartlett MS, Movellan JR. Multilayer Architectures for Facial Action Unit Recognition. IEEE Trans Syst Man Cybern B Cybern. 2012 Aug; 42(4):1027-38. PMID: 22588611.
      Citations: 3     Fields:    
    44. Konopleva M, Milella M, Ruvolo P, Watts JC, Ricciardi MR, Korchin B, McQueen T, Bornmann W, Tsao T, Bergamo P, Mak DH, Chen W, McCubrey J, Tafuri A, Andreeff M. MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex. Leukemia. 2012 Apr; 26(4):778-87. PMID: 22064351.
      Citations: 65     Fields:    Translation:HumansAnimalsCells
    45. Ruvolo PP, Qui YH, Coombes KR, Zhang N, Ruvolo VR, Borthakur G, Konopleva M, Andreeff M, Kornblau SM. Low expression of PP2A regulatory subunit B55a is associated with T308 phosphorylation of AKT and shorter complete remission duration in acute myeloid leukemia patients. Leukemia. 2011 Nov; 25(11):1711-7. PMID: 21660042.
      Citations: 34     Fields:    Translation:HumansCells
    46. Ruvolo PP, Zhou L, Watt JC, Ruvolo VR, Burks JK, Jiffar T, Kornblau S, Konopleva M, Andreeff M. Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells. J Cell Biochem. 2011 Jun; 112(6):1696-707. PMID: 21360576.
      Citations: 21     Fields:    Translation:HumansCells
    47. Steelman LS, Franklin RA, Abrams SL, Chappell W, Kempf CR, Bäsecke J, Stivala F, Donia M, Fagone P, Nicoletti F, Libra M, Ruvolo P, Ruvolo V, Evangelisti C, Martelli AM, McCubrey JA. Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. Leukemia. 2011 Jul; 25(7):1080-94. PMID: 21494257.
      Citations: 82     Fields:    Translation:HumansCells
    48. Martelli AM, Evangelisti C, Chappell W, Abrams SL, Bäsecke J, Stivala F, Donia M, Fagone P, Nicoletti F, Libra M, Ruvolo V, Ruvolo P, Kempf CR, Steelman LS, McCubrey JA. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway. Leukemia. 2011 Jul; 25(7):1064-79. PMID: 21436840.
      Citations: 73     Fields:    Translation:HumansCells
    49. Zou X, Gao Y, Ruvolo VR, Gardner TL, Ruvolo PP, Brown RE. Human glycolipid transfer protein gene (GLTP) expression is regulated by Sp1 and Sp3: involvement of the bioactive sphingolipid ceramide. J Biol Chem. 2011 Jan 14; 286(2):1301-11. PMID: 20974858.
      Citations: 8     Fields:    Translation:HumansCells
    50. Ruvolo VR, Karanjeet KB, Schuster TF, Brown R, Deng Y, Hinchcliffe E, Ruvolo PP. Role for PKC d in Fenretinide-Mediated Apoptosis in Lymphoid Leukemia Cells. J Signal Transduct. 2010 Jan 01; 2010:584657. PMID: 20844597.
      Citations: 9     
    51. Johnson TE, Kassie F, O'Sullivan MG, Negia M, Hanson TE, Upadhyaya P, Ruvolo PP, Hecht SS, Xing C. Chemopreventive effect of kava on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo[a]pyrene-induced lung tumorigenesis in A/J mice. Cancer Prev Res (Phila). 2008 Nov; 1(6):430-8. PMID: 19138990.
      Citations: 12     Fields:    Translation:Animals
    52. Nica AF, Tsao CC, Watt JC, Jiffar T, Kurinna S, Jurasz P, Konopleva M, Andreeff M, Radomski MW, Ruvolo PP. Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK. Cell Cycle. 2008 Nov 01; 7(21):3362-70. PMID: 18948750.
      Citations: 20     Translation:HumansCells
    53. Ruvolo VR, Kurinna SM, Karanjeet KB, Schuster TF, Martelli AM, McCubrey JA, Ruvolo PP. PKR regulates B56(alpha)-mediated BCL2 phosphatase activity in acute lymphoblastic leukemia-derived REH cells. J Biol Chem. 2008 Dec 19; 283(51):35474-85. PMID: 18957415.
      Citations: 20     Fields:    Translation:HumansCells
    54. Wu X, Carr HS, Dan I, Ruvolo PP, Frost JA. p21 activated kinase 5 activates Raf-1 and targets it to mitochondria. J Cell Biochem. 2008 Sep 01; 105(1):167-75. PMID: 18465753.
      Citations: 24     Fields:    Translation:HumansCells
    55. Samudio I, Kurinna S, Ruvolo P, Korchin B, Kantarjian H, Beran M, Dunner K, Kondo S, Andreeff M, Konopleva M. Inhibition of mitochondrial metabolism by methyl-2-cyano-3,12-dioxooleana-1,9-diene-28-oate induces apoptotic or autophagic cell death in chronic myeloid leukemia cells. Mol Cancer Ther. 2008 May; 7(5):1130-9. PMID: 18483301.
      Citations: 24     Translation:HumansCells
    56. Kong G, Wang D, Wang H, Wu J, Bielawski J, Konopleva M, Andreeff M, Ruvolo PP, Maurer BJ. Synthetic triterpenoids have cytotoxicity in pediatric acute lymphoblastic leukemia cell lines but cytotoxicity is independent of induced ceramide increase in MOLT-4 cells. Leukemia. 2008 Jun; 22(6):1258-62. PMID: 18033322.
      Citations: 3     Fields:    Translation:HumansCells
    57. Tsao CC, Nica AF, Kurinna SM, Jiffar T, Mumby M, Ruvolo PP. Mitochondrial protein phosphatase 2A regulates cell death induced by simulated ischemia in kidney NRK-52E cells. Cell Cycle. 2007 Oct 01; 6(19):2377-85. PMID: 17700073.
      Citations: 10     Translation:AnimalsCells
    58. Tabe Y, Jin L, Contractor R, Gold D, Ruvolo P, Radke S, Xu Y, Tsutusmi-Ishii Y, Miyake K, Miyake N, Kondo S, Ohsaka A, Nagaoka I, Andreeff M, Konopleva M. Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1. Cell Death Differ. 2007 Aug; 14(8):1443-56. PMID: 17464329.
      Citations: 25     Fields:    Translation:HumansCells
    59. Seminara AR, Ruvolo PP, Murad F. LPS/IFNgamma-induced RAW 264.7 apoptosis is regulated by both nitric oxide-dependent and -independent pathways involving JNK and the Bcl-2 family. Cell Cycle. 2007 Jul 15; 6(14):1772-8. PMID: 17622798.
      Citations: 9     Translation:HumansAnimalsCells
    60. Konopleva M, Contractor R, Tsao T, Samudio I, Ruvolo PP, Kitada S, Deng X, Zhai D, Shi YX, Sneed T, Verhaegen M, Soengas M, Ruvolo VR, McQueen T, Schober WD, Watt JC, Jiffar T, Ling X, Marini FC, Harris D, Dietrich M, Estrov Z, McCubrey J, May WS, Reed JC, Andreeff M. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell. 2006 Nov; 10(5):375-88. PMID: 17097560.
      Citations: 414     Fields:    Translation:HumansAnimalsCells
    61. Kurinna S, Konopleva M, Palla SL, Chen W, Kornblau S, Contractor R, Deng X, May WS, Andreeff M, Ruvolo PP. Bcl2 phosphorylation and active PKC alpha are associated with poor survival in AML. Leukemia. 2006 Jul; 20(7):1316-9. PMID: 16642043.
      Citations: 17     Fields:    Translation:HumansCells
    62. Alonso-Escolano D, Medina C, Cieslik K, Radomski A, Jurasz P, Santos-Martínez MJ, Jiffar T, Ruvolo P, Radomski MW. Protein kinase C delta mediates platelet-induced breast cancer cell invasion. J Pharmacol Exp Ther. 2006 Jul; 318(1):373-80. PMID: 16617167.
      Citations: 15     Fields:    Translation:HumansCells
    63. Konopleva M, Contractor R, Kurinna SM, Chen W, Andreeff M, Ruvolo PP. The novel triterpenoid CDDO-Me suppresses MAPK pathways and promotes p38 activation in acute myeloid leukemia cells. Leukemia. 2005 Aug; 19(8):1350-4. PMID: 15931262.
      Citations: 35     Fields:    Translation:HumansCells
    64. Kurinna SM, Tsao CC, Nica AF, Jiffar T, Ruvolo PP. Ceramide promotes apoptosis in lung cancer-derived A549 cells by a mechanism involving c-Jun NH2-terminal kinase. Cancer Res. 2004 Nov 01; 64(21):7852-6. PMID: 15520191.
      Citations: 35     Fields:    Translation:HumansCells
    65. Tacke F, Marini FC, Zhao S, McQueen T, Konopleva M, Ruvolo PP, Hu SX, Xu HJ, Andreeff M. Expression of inducible Bcl-X(S) in myeloid leukemia: compensatory upregulation of Bcl-X(L) and Bcl-2 prevents apoptosis and chemosensitization. Cancer Biol Ther. 2004 Mar; 3(3):340-7. PMID: 14726688.
      Citations: 2     Translation:HumansCells
    66. Jiffar T, Kurinna S, Suck G, Carlson-Bremer D, Ricciardi MR, Konopleva M, Andreeff M, Ruvolo PP. PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation. Leukemia. 2004 Mar; 18(3):505-12. PMID: 14737078.
      Citations: 19     Fields:    Translation:HumansCells
    67. Andreeff M, Milella M, Carter BZ, Tabe Y, Ricciardi MR, Sneed T, Ruvolo P, Contractor R, Tsao T, Schober W, Evans R, McQueen T, Zeng Z, Kornblau SM, McCubrey J, Estey E, Mills GB, Reed JC, Konopleva M. Targeted therapy of AML new concepts. Ann Hematol. 2004; 83 Suppl 1:S51-3. PMID: 15124670.
      Citations: 5     Fields:    Translation:HumansCells
    68. Johnson CR, Jiffar T, Fischer UM, Ruvolo PP, Jarvis WD. Requirement for SAPK-JNK signaling in the induction of apoptosis by ribosomal stress in REH lymphoid leukemia cells. Leukemia. 2003 Nov; 17(11):2140-8. PMID: 12970763.
      Citations: 2     Fields:    Translation:HumansCells
    69. Ruvolo PP. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol Res. 2003 May; 47(5):383-92. PMID: 12676512.
      Citations: 94     Fields:    Translation:AnimalsCells
    70. Varma T, Liu SQ, West M, Thongboonkerd V, Ruvolo PP, May WS, Bhatnagar A. Protein kinase C-dependent phosphorylation and mitochondrial translocation of aldose reductase. FEBS Lett. 2003 Jan 16; 534(1-3):175-9. PMID: 12527382.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    71. May WS, Ruvolo PP. Bryostatin-I: an antineoplastic treasure from the deep? Cancer Biol Ther. 2002 Jul-Aug; 1(4):417-9. PMID: 12432258.
      Citations: 1     Translation:HumansAnimals
    72. Ruvolo PP, Clark W, Mumby M, Gao F, May WS. A functional role for the B56 alpha-subunit of protein phosphatase 2A in ceramide-mediated regulation of Bcl2 phosphorylation status and function. J Biol Chem. 2002 Jun 21; 277(25):22847-52. PMID: 11929874.
      Citations: 50     Fields:    Translation:HumansCells
    73. Konopleva M, Tsao T, Ruvolo P, Stiouf I, Estrov Z, Leysath CE, Zhao S, Harris D, Chang S, Jackson CE, Munsell M, Suh N, Gribble G, Honda T, May WS, Sporn MB, Andreeff M. Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia. Blood. 2002 Jan 01; 99(1):326-35. PMID: 11756188.
      Citations: 69     Fields:    Translation:HumansCells
    74. Ruvolo PP. Ceramide regulates cellular homeostasis via diverse stress signaling pathways. Leukemia. 2001 Aug; 15(8):1153-60. PMID: 11480555.
      Citations: 36     Fields:    Translation:HumansAnimalsCells
    75. Deng X, Xiao L, Lang W, Gao F, Ruvolo P, May WS. Novel role for JNK as a stress-activated Bcl2 kinase. J Biol Chem. 2001 Jun 29; 276(26):23681-8. PMID: 11323415.
      Citations: 81     Fields:    Translation:AnimalsCells
    76. Ruvolo PP, Deng X, May WS. Phosphorylation of Bcl2 and regulation of apoptosis. Leukemia. 2001 Apr; 15(4):515-22. PMID: 11368354.
      Citations: 108     Fields:    Translation:HumansAnimalsCells
    77. Ruvolo PP, Gao F, Blalock WL, Deng X, May WS. Ceramide regulates protein synthesis by a novel mechanism involving the cellular PKR activator RAX. J Biol Chem. 2001 Apr 13; 276(15):11754-8. PMID: 11148216.
      Citations: 21     Fields:    Translation:AnimalsCells
    78. Deng X, Kornblau SM, Ruvolo PP, May WS. Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistance. J Natl Cancer Inst Monogr. 2001; (28):30-7. PMID: 11158204.
      Citations: 26     Fields:    Translation:HumansCells
    79. Kornblau SM, Vu HT, Ruvolo P, Estrov Z, O'Brien S, Cortes J, Kantarjian H, Andreeff M, May WS. BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia. Clin Cancer Res. 2000 Apr; 6(4):1401-9. PMID: 10778970.
      Citations: 13     Fields:    Translation:HumansCells
    80. Deng X, Ruvolo P, Carr B, May WS. Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases. Proc Natl Acad Sci U S A. 2000 Feb 15; 97(4):1578-83. PMID: 10677502.
      Citations: 58     Fields:    Translation:AnimalsCells
    81. Ruvolo PP, Deng X, Ito T, Carr BK, May WS. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J Biol Chem. 1999 Jul 16; 274(29):20296-300. PMID: 10400650.
      Citations: 72     Fields:    Translation:HumansAnimalsCells
    82. Ruvolo PP, Deng X, Carr BK, May WS. A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem. 1998 Sep 25; 273(39):25436-42. PMID: 9738012.
      Citations: 80     Fields:    Translation:HumansCells
    83. Hess A, Ruvolo P, Fischer A, Horwitz L, Bright E, Thoburn C. Characterization of the V alpha/V beta autoreactive T-cell repertoire in syngeneic graft-vs-host disease. Transplant Proc. 1997 Feb-Mar; 29(1-2):709-11. PMID: 9123492.
      Citations:    Fields:    Translation:AnimalsCells
    84. Hess AD, Kennedy MJ, Ruvolo PP, Vogelsang GB, Jones RJ. Antitumor activity of syngeneic/autologous graft-versus-host disease. Ann N Y Acad Sci. 1995 Dec 29; 770:189-202. PMID: 8597360.
      Citations:    Fields:    Translation:HumansAnimals
    85. Zhang H, Horwitz L, Ruvolo P, Colombani P, Hess AD. The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection. Transplantation. 1995 Jul 27; 60(2):115-22. PMID: 7624952.
      Citations: 2     Fields:    Translation:AnimalsCells
    86. Ruvolo PP, Fischer AC, Vogelsang GB, Jones RJ, Hess AD. Analysis of the V beta T-cell receptor repertoire in autologous graft-versus-host disease. Ann N Y Acad Sci. 1995 Jul 07; 756:432-4. PMID: 7645866.
      Citations:    Fields:    Translation:HumansCells
    87. Burt RK, Burns W, Ruvolo P, Fischer A, Shiao C, Guimaraes A, Barrett J, Hess A. Syngeneic bone marrow transplantation eliminates V beta 8.2 T lymphocytes from the spinal cord of Lewis rats with experimental allergic encephalomyelitis. J Neurosci Res. 1995 Jul 01; 41(4):526-31. PMID: 7473884.
      Citations: 7     Fields:    Translation:AnimalsCellsPHPublic Health
    88. Fischer AC, Ruvolo PP, Burt R, Horwitz LR, Bright EC, Hess JM, Beschorner WE, Hess AD. Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression. J Immunol. 1995 Apr 15; 154(8):3713-25. PMID: 7706714.
      Citations: 3     Fields:    Translation:AnimalsCells
    89. Fischer AC, Ruvolo PP, Horwitz LR, Hess AD. Analysis of V beta T-cell receptor repertoire of effector mechanisms in acute and chronic graft versus host disease. Transplant Proc. 1995 Feb; 27(1):1366-9. PMID: 7878914.
      Citations:    Fields:    Translation:AnimalsCells
    90. Ruvolo P, Bright E, Kennedy MJ, Morris L, Fischer A, Vogelsang G, Jones R, Hess A. Cyclosporine-induced autologous graft versus host disease: assessment of cytolytic effector mechanisms and the V beta T-cell receptor repertoire. Transplant Proc. 1995 Feb; 27(1):1363-5. PMID: 7878913.
      Citations: 2     Fields:    Translation:HumansCells
    91. Ruvolo PP, Keating KM, Williams KR, Chase JW. Single-stranded DNA binding proteins (SSBs) from prokaryotic transmissible plasmids. Proteins. 1991; 9(2):120-34. PMID: 2008432.
      Citations: 7     Fields:    Translation:Cells
    92. Casas-Finet JR, Jhon NI, Khamis MI, Maki AH, Ruvolo PP, Chase JW. An IncY plasmid-encoded single-stranded DNA-binding protein from Escherichia coli shows the identical pattern of stacked tryptophan residues as the chromosomal ssb gene product. Eur J Biochem. 1988 Dec 01; 178(1):101-7. PMID: 3060358.
      Citations: 3     Fields:    Translation:Cells
    93. Casas-Finet JR, Khamis MI, Maki AH, Ruvolo PP, Chase JW. Optically detected magnetic resonance of tryptophan residues in Escherichia coli ssb gene product and E. coli plasmid-encoded single-stranded DNA-binding proteins and their complexes with poly(deoxythymidylic) acid. J Biol Chem. 1987 Jun 25; 262(18):8574-83. PMID: 3298237.
      Citations: 5     Fields:    Translation:Cells
    94. Khamis MI, Casas-Finet JR, Maki AH, Ruvolo PP, Chase JW. Optically detected magnetic resonance of tryptophan residues in complexes formed between a bacterial single-stranded DNA binding protein and heavy atom modified poly(uridylic acid). Biochemistry. 1987 Jun 16; 26(12):3347-54. PMID: 3307905.
      Citations: 3     Fields:    Translation:Cells
    95. Smith CL, Siegfried E, Ruvolo PP. Adaptive doses of MNNG efficiently induce a recA-trp gene fusion. DNA. 1983; 2(4):291-9. PMID: 6363023.
      Citations: 3     Fields:    Translation:Cells
    96. Editorial. Frontiers in Oncology. 6.
    97. JNK functions as a stress-activated and interleukin-3 agonist-activated Bcl2 kinase. Cancer Control. 6:612.
    98. MDM2 inhibitor, Nutlin 3a, induces p53 dependent autophagy in acute leukemia by AMP kinase activation. PLoS One. 10.
    99. ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies. Science Signaling. 9.
    100. A role for PKR and the cellular PKR activator, RAX, in the potentiation of ceramide-induced apoptosis in hematopoietic cells. Blood. 96.
    101. Phosphorylation of GSK3α/β correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients. BBA Clinical. 4:59-68.
    102. The interplay between PP2A and microRNAs in leukemia. Frontiers in Oncology. 5.
    103. PKC a is a physiologic BCL2 kinase. Experimental Hematology. 26:751.
    104. BBA Clinical. 6:87-99.
    105. The potential of enzastaurin to enhance platelet aggregation and growth factor secretion. Journal of Thrombosis and Haemostasis. 13:1514-1520.
    106. Galectin 3 as a guardian of the tumor microenvironment. Biochimica et Biophysica Acta - Molecular Cell Research. 1863:427-437.
    107. Ceramide-driven stress signals in cancer and aging. Advances in Cell Aging and Gerontology. 12:47-69.
    108. Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells. Biochimica et Biophysica Acta - Molecular Cell Research. 1863:562-571.
    RUVOLO's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (454)
    Explore
    _
    Co-Authors (62)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _